NASDAQ:SYRS

Syros Pharmaceuticals Stock Insider Trading

etoro logo Buy SYRS
*Your capital is at risk
$0.0002
+0 (+0%)
At Close: Jun 02, 2026

Syros Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 28.21. In total, the insiders bought 1.07M and sold 1.21M SYRS shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
28.21
Buy 1.07M shares
Sell 1.21M shares
74% Buy Activity
Weak Negative Correlation
Buy Signal Medium Confidence
Jun 01, 2026

Analysis Breakdown:

  • Supported by a positive Insider Power Score of 28.21.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Jun 05, 2024
Buy
Restricted Stock Units
A-Award
Dunsire Deborah
Director
Director 4 000
Value: $21.2K
Jun 05, 2024
Buy
Common Stock
A-Award
Oh Andrew M.
Director
Director 4 000
Value: $21.2K
Jun 05, 2024
Buy
Common Stock
A-Award
Eckhardt Sue Gail
Director
Director 4 000
Value: $21.2K
Jun 05, 2024
Buy
Stock Option (right to buy)
A-Award
Oh Andrew M.
Director
Director 6 000
Value: $31.8K
Jun 05, 2024
Buy
Stock Option (right to buy)
A-Award
Eckhardt Sue Gail
Director
Director 6 000
Value: $31.8K
Jun 05, 2024
Buy
Common Stock
A-Award
Fanucci Marsha
Director
Director 4 000
Value: $21.2K
Jun 05, 2024
Buy
Stock Option (right to buy)
A-Award
Fanucci Marsha
Director
Director 6 000
Value: $31.8K
Jun 05, 2024
Buy
Stock Option (right to buy)
A-Award
Akkaraju Srinivas
Director
Director 6 000
Value: $31.8K
Jun 05, 2024
Buy
Restricted Stock Units
A-Award
Akkaraju Srinivas
Director
Director 4 000
Value: $21.2K
Jun 05, 2024
Buy
Common Stock
A-Award
Wirth Peter
Director
Director 4 000
Value: $21.2K
Jun 05, 2024
Buy
Stock Option (right to buy)
A-Award
Wirth Peter
Director
Director 6 000
Value: $31.8K
Jun 05, 2024
Buy
Stock Option (right to buy)
A-Award
Akkaraju Srinivas
Director
Director 6 000
Value: $31.8K
Jun 05, 2024
Buy
Stock Option (right to buy)
A-Award
Fanucci Marsha
Director
Director 6 000
Value: $31.8K
Jun 05, 2024
Buy
Common Stock
A-Award
Fanucci Marsha
Director
Director 4 000
Value: $21.2K
Jun 05, 2024
Buy
Stock Option (right to buy)
A-Award
Eckhardt Sue Gail
Director
Director 6 000
Value: $31.8K
Jun 05, 2024
Buy
Stock Option (right to buy)
A-Award
Oh Andrew M.
Director
Director 6 000
Value: $31.8K
Jun 05, 2024
Buy
Common Stock
A-Award
Eckhardt Sue Gail
Director
Director 4 000
Value: $21.2K
Jun 05, 2024
Buy
Common Stock
A-Award
Oh Andrew M.
Director
Director 4 000
Value: $21.2K
Jun 05, 2024
Buy
Restricted Stock Units
A-Award
Dunsire Deborah
Director
Director 4 000
Value: $21.2K
Jun 05, 2024
Buy
Stock Option (right to buy)
A-Award
Dunsire Deborah
Director
Director 6 000
Value: $31.8K
Jun 05, 2024
Buy
Restricted Stock Units
A-Award
Akkaraju Srinivas
Director
Director 4 000
Value: $21.2K
Jun 05, 2024
Buy
Common Stock
A-Award
Wirth Peter
Director
Director 4 000
Value: $21.2K
Jun 05, 2024
Buy
Stock Option (right to buy)
A-Award
Wirth Peter
Director
Director 6 000
Value: $31.8K
Jun 05, 2024
Buy
Stock Option (right to buy)
A-Award
Simonian Nancy A
Director
Director 6 000
Value: $31.8K
Jun 05, 2024
Buy
Common Stock
A-Award
Simonian Nancy A
Director
Director 4 000
Value: $21.2K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT SYROS PHARMACEUTICALS
Syros Pharmaceuticals
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically defined subset of patients with myelodysplastic syndrome and Phase II clinical trial for patients with acu...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE